- Trials with a EudraCT protocol (58)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
58 result(s) found for: Assisted ventilation.
Displaying page 1 of 3.
EudraCT Number: 2007-006742-18 | Sponsor Protocol Number: P070106 | Start Date*: 2010-08-25 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Evaluation de l'intérêt de la loxapine dans le contrôle de l'agitation au cours du sevrage de la ventilation mécanique. Etude randomisée, contrôlée. | |||||||||||||
Medical condition: Agitation au cours du sevrage de la ventilation mécanique | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022679-71 | Sponsor Protocol Number: Xenon-MTH-Studie | Start Date*: 2011-01-07 | |||||||||||
Sponsor Name:Clinical Trials Center Aachen, University of Aachen | |||||||||||||
Full Title: Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation | |||||||||||||
Medical condition: In this clinical trial will be checked, whether 2 hours ventilation with xenon has neuroprotetctive effect on the patients, which had out of hospital cardiac arrest and successful cardiopulmonary r... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003457-24 | Sponsor Protocol Number: P051018 | Start Date*: 2007-02-07 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Sevrage de la ventilation mécanique guidé par le peptide natriurétique de type B. | |||||||||||||
Medical condition: Patients sous ventilation mécanique. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002201-66 | Sponsor Protocol Number: CBYM338X2207 | Start Date*: 2013-11-01 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An exploratory, randomized, double-blind, placebo-controlled study to investigate the effect of BYM338 on muscle in patients requiring prolonged mechanical ventilation | |||||||||||||
Medical condition: Group III failure to wean patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010366-28 | Sponsor Protocol Number: 69/09 | Start Date*: 2009-06-13 | |||||||||||||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||||||||||||
Full Title: Effects of different doses of remifentanil in patients ventilated in Pressure Support Ventilation (PSV) vs Neurally Adjusted Ventilatory Assist (NAVA) | |||||||||||||||||||||||
Medical condition: Acute Respiratory Failure (ARF) or with a difficult weaning in patients ventilated | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003338-15 | Sponsor Protocol Number: RBHP2014ELJEZI | Start Date*: 2014-12-01 | |||||||||||
Sponsor Name:CHU de Clermont-Ferrand | |||||||||||||
Full Title: Role of Nitric Oxide (NO) in pre-oxygenation before anesthetic induction in patients with Pulmonary Hypertension (PH) in cardiac surgery. Feasibility study. | |||||||||||||
Medical condition: - Cardiac surgery open heart - Pulmonary Hypertension with PAPs> 40 mmHg secondary to left heart disease or COPD (class 2 or 3), diagnosed by preoperative right heart catheterization or transthora... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005676-25 | Sponsor Protocol Number: AC16025 | Start Date*: 2016-08-31 | ||||||||||||||||
Sponsor Name:University of Edinburgh [...] | ||||||||||||||||||
Full Title: Sensing using Neutrophil Activation Probe on the Intensive Therapy Unit | ||||||||||||||||||
Medical condition: Critical illness requiring ventilation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002555-34 | Sponsor Protocol Number: ECSEVO-LT-011 | Start Date*: 2011-11-25 | |||||||||||
Sponsor Name:FRANCISCO JAVIER BELDA | |||||||||||||
Full Title: Study on the safety of administration of sevoflurane for long-term sedation in critical patients on assisted ventilation. A multicentric, randomised, controlled, prospective clinical trial. | |||||||||||||
Medical condition: The general objective of this study is to perform an assessment of the safety of administration of sevoflurane for prolonged sedation of patients admitted to the Critical Care Unit. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000735-80 | Sponsor Protocol Number: 2010-382 | Start Date*: 2011-05-16 |
Sponsor Name:Lene Drasbek Huusom | ||
Full Title: Administration of antenatal magnesium sulphate for prevention of cerebral palsy in preterm infants (MASP-STUDY) | ||
Medical condition: Moderate to severe cerebral palsy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001768-39 | Sponsor Protocol Number: SURFABRON | Start Date*: 2018-03-07 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: Randomized multicentre-controlled, placebo-controlled (1: 1) study to evaluate the efficacy and safety of Curosurf in patients under 12 months of age with moderate or severe acute respiratory distr... | |||||||||||||
Medical condition: Acute severe hypoxic bronchiolitis | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008143-24 | Sponsor Protocol Number: gas alogenati | Start Date*: 2009-02-12 |
Sponsor Name:AZIENDA OSPEDALIERA SAN GERARDO DI MONZA | ||
Full Title: Inhalatorial sedation in patient with SAH versus conventional intravenus sedation | ||
Medical condition: sub-arachnoid haemorrage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002110-22 | Sponsor Protocol Number: LTA-2-2008 | Start Date*: 2008-09-16 | |||||||||||
Sponsor Name:Prof. dr L.H. van den Berg, UMC-Utrecht | |||||||||||||
Full Title: A randomised sequential trial of Lithium in amyotrophic lateral sclerosis | |||||||||||||
Medical condition: Amyotrophic lateral sclerosis (ALS) is a disease characterised by progressive degeneration of motor neurons in brain and spinal cord leading to muscle weakness. ALS can occur at anytime in adulthoo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005059-35 | Sponsor Protocol Number: TMP-2204-2021-47 | Start Date*: 2022-01-25 | ||||||||||||||||
Sponsor Name:F4-Pharma GmbH i.G. | ||||||||||||||||||
Full Title: Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0) | ||||||||||||||||||
Medical condition: Acute Respiratory Distress Syndrome (ARDS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Trial now transitioned) ES (Ongoing) LT (Trial now transitioned) PT (Prematurely Ended) IT (Prematurely Ended) NL (Completed) RO (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008439-28 | Sponsor Protocol Number: 1682/08 | Start Date*: 2009-03-22 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Effects of the addition of haloperidol on propofol requirements during sedation with propofol and remifentanil | |||||||||||||
Medical condition: analgo-sedation in mechanically ventilated patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001336-10 | Sponsor Protocol Number: AGNES-19 | Start Date*: 2022-03-25 | |||||||||||
Sponsor Name:University Medical Centre Hamburg-Eppendorf | |||||||||||||
Full Title: Multicenter, randomized, double-blind, biomarker-guided, phase II trial with Adrecizumab (HAM 8101) to improve proGNosis and outcomES in patients with moderate to severe covid-19 - Adrecizumab (HAM... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004160-58 | Sponsor Protocol Number: CHASAP | Start Date*: 2021-06-11 | ||||||||||||||||
Sponsor Name:Centre hospitalier intercommunal de Créteil | ||||||||||||||||||
Full Title: Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled trial | ||||||||||||||||||
Medical condition: Pregnant women with chronic hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001156-18 | Sponsor Protocol Number: PanCOVID19 | Start Date*: 2020-03-27 |
Sponsor Name:Fundación para la investigación Biomedica Hospital Universitario La Paz | ||
Full Title: Randomized clinical trial to evaluate the efficacy of different treatments in patients with COVID-19 who require hospitalization | ||
Medical condition: Patients infected with COVID19 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2020-005580-32 | Sponsor Protocol Number: Sili | Start Date*: 2021-04-26 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Pilot study on silibinin as a possible therapeutic agent for mildly ill COVID-19 patients | ||
Medical condition: antiviral effect of silibinin against SARS-CoV2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002348-33 | Sponsor Protocol Number: A35-011 | Start Date*: 2022-12-22 | |||||||||||
Sponsor Name:Amylyx Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase IIIb, Open Label Extension Study Evaluating The Safety And Tolerability of AMX0035 Up To 108 Weeks In Adult Participants with Amyotrophic Lateral Sclerosis (ALS) Previously Enrolled In Stud... | |||||||||||||
Medical condition: ALS (amyotrophic lateral sclerosis) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) NL (Completed) IT (Prematurely Ended) FR (Prematurely Ended) PL (Prematurely Ended) BE (Completed) PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001673-75 | Sponsor Protocol Number: ABX464-401 | Start Date*: 2020-05-06 |
Sponsor Name:ABIVAX | ||
Full Title: A phase 2/3, randomized, double blind, placebo-controlled study to evaluate the efficacy and the safety of ABX464 in treating inflammation and preventing COVID-19 associated acute respiratory failu... | ||
Medical condition: COVID-19 infection (infection with SARS-CoV-2 virus) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) BE (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
